Cite
HARVARD Citation
Moore, K. et al. (2018). Does a Central Stereotactic Ablative Radiotherapy (SABR) Multidisciplinary Team (MDT) for Early Stage Lung Cancer Influence Patient Outcome?. Clinical oncology. 30 (6), pp. e62-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moore, K. et al. (2018). Does a Central Stereotactic Ablative Radiotherapy (SABR) Multidisciplinary Team (MDT) for Early Stage Lung Cancer Influence Patient Outcome?. Clinical oncology. 30 (6), pp. e62-. [Online].